Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Glenn Palomaki

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Disorders

Down Syndrome

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

False Positive Reactions

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
89
Haddow, James
51
Knight, George
40
Neveux, Louis
29
Canick, Jacob
20
Craig, Wendy
18
Ritchie, Robert
16
Bradley, Linda
14
Lambert-Messerlian, Geralyn
14
Navolotskaia, Olga
13
Ledue, Thomas
11
Lustig, Viliam
11
Macrae, Andrew
11
Jaffe, Allan
11
Kavsak, Peter
9
Ko, Dennis

Sign-in to see all Coauthors

Publications

TOP 3
Palomaki Glenn E; Lee Jo Ellen S; Canick Jacob A; McDowell Geraldine A; Donnenfeld Alan E;
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements.
Marcos Josep; Craig Wendy Y; Palomaki Glenn E; Kloza Edward M; Haddow James E; Roberson Marie; Bradley Linda A; Shackleton Cedric H L
Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies.
Palomaki Glenn E; Bradley Linda A; Douglas Michael P; Kolor Katherine; Dotson W David
Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Glenn Palomaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Palomaki Glenn E; Lee Jo Ellen S; Canick Jacob A; McDowell Geraldine A; Donnenfeld Alan E;
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(9):669-81.
2009: Marcos Josep; Craig Wendy Y; Palomaki Glenn E; Kloza Edward M; Haddow James E; Roberson Marie; Bradley Linda A; Shackleton Cedric H L
Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies.
Prenatal diagnosis 2009;29(8):771-80.
2009: Palomaki Glenn E; Bradley Linda A; Douglas Michael P; Kolor Katherine; Dotson W David
Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(1):21-34.
2009: Palomaki Glenn E; McClain Monica R; Melillo Stephanie; Hampel Heather L; Thibodeau Stephen N
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(1):42-65.
2009: Teutsch Steven M; Bradley Linda A; Palomaki Glenn E; Haddow James E; Piper Margaret; Calonge Ned; Dotson W David; Douglas Michael P; Berg Alfred O;
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(1):3-14.
2009: Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A
Adjustment of serum markers in first trimester screening.
Journal of medical screening 2009;16(2):102-3.
2008: Haddow James E; McClain Monica R; Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
The Journal of clinical endocrinology and metabolism 2008;93(9):3341-7.
2008: McClain Monica R; Lambert-Messerlian Geralyn; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.
American journal of obstetrics and gynecology 2008;199(2):129.e1-6.
2008: Lambert-Messerlian Geralyn; McClain Monica; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
American journal of obstetrics and gynecology 2008;199(1):62.e1-6.
2008: Lambert-Messerlian G M; Palomaki G E; Canick J A
Inhibin A measurement using an automated assay platform.
Prenatal diagnosis 2008;28(5):399-403.
2008: Kavsak Peter A; Newman Alice M; Ko Dennis T; Palomaki Glenn E; Lustig Viliam; MacRae Andrew R; Jaffe Allan S
Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?
Clinical chemistry 2008;54(4):747-51.
2008: Kavsak Peter A; Ko Dennis T; Newman Alice M; Lustig Viliam; Palomaki Glenn E; MacRae Andrew R; Jaffe Allan S
Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?
Clinical biochemistry 2008;41(6):436-9.
2008: Palomaki Glenn E; Neveux Louis M; Donnenfeld Alan; Lee Jo Ellen S; McDowell Geraldine; Canick Jacob A; Summers Anne; Lambert-Messerlian Geralyn; Kellner Leonard H; Zebelman Arthur; Haddow James E
Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):131-8.
2008: McClain Monica R; Palomaki Glenn E; Piper Margaret; Haddow James E
A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):89-98.
2008: Monaghan Kristin G; Feldman Gerald L; Palomaki Glenn E; Spector Elaine B;
Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(1):57-72.
2008: Kavsak Peter A; Ko Dennis T; Newman Alice M; Palomaki Glenn E; Lustig Viliam; Macrae Andrew R; Jaffe Allan S
"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.
Clinica chimica acta; international journal of clinical chemistry 2008;387(1-2):133-8.
2008: McClain Monica R; Palomaki Glenn E; Hampel Heather; Westman Judith A; Haddow James E
Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women.
Familial cancer 2008;7(4):341-5.
2007: Kavsak Peter A; Ko Dennis T; Newman Alice M; Palomaki Glenn E; Lustig Viliam; MacRae Andrew R; Jaffe Allan S
Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.
Clinical chemistry 2007;53(12):2112-8.
2007: Shackleton Cedric H L; Marcos Josep; Palomaki Glenn E; Craig Wendy Y; Kelley Richard I; Kratz Lisa E; Haddow James E
Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS).
American journal of medical genetics. Part A 2007;143A(18):2129-36.
2007: Palomaki Glenn E; Neveux Louis M; Haddow James E; Wyatt Philip
Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
Prenatal diagnosis 2007;27(9):808-13.
2007: Gudgeon James M; McClain Monica R; Palomaki Glenn E; Williams Marc S
Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(7):473-8.
2007: Palomaki Glenn E; Neveux Louis M; Knight George J; Haddow James E; Lee JoEllen
Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh sera.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(7):458-63.
2007: McClain Monica R; Palomaki Glenn E; Haddow James E
How reliable are BRCA1/2 mutation estimates?
Cancer research 2007;67(10):5057; author reply 5057-8.
2007: Kavsak Peter A; MacRae Andrew R; Lustig Viliam; Newman Alice M; Ko Dennis T; Tu Jack V; Palomaki Glenn E; Jaffe Allan S
Authors' response to Apple editorial.
Clinica chimica acta; international journal of clinical chemistry 2007;380(1-2):245-6.
2007: Kavsak Peter A; MacRae Andrew R; Newman Alice M; Lustig Viliam; Palomaki Glenn E; Ko Dennis T; Tu Jack V; Jaffe Allan S
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.
Clinica chimica acta; international journal of clinical chemistry 2007;380(1-2):213-6.
2007: Craig Wendy Y; Haddow James E; Palomaki Glenn E; Roberson Marie
Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
Prenatal diagnosis 2007;27(5):409-14.
2007: Kavsak Peter A; MacRae Andrew R; Newman Alice M; Lustig Viliam; Palomaki Glenn E; Ko Dennis T; Tu Jack V; Jaffe Allan S
Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.
Clinical biochemistry 2007;40(5-6):326-9.
2007: Haddow James E; McClain Monica R; Palomaki Glenn E; Hollowell Joseph G
Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population.
The Journal of clinical endocrinology and metabolism 2007;92(3):1019-22.
2007: Kavsak Peter A; Newman Alice M; Lustig Viliam; MacRae Andrew R; Palomaki Glenn E; Ko Dennis T; Tu Jack V; Jaffe Allan S
Long-term health outcomes associated with detectable troponin I concentrations.
Clinical chemistry 2007;53(2):220-7.
2007: Palomaki Glenn E; Lambert-Messerlian Geralyn M; Canick Jacob A
A summary analysis of Down syndrome markers in the late first trimester.
Advances in clinical chemistry 2007;43():177-210.
2006: Canick Jacob A; Lambert-Messerlian Geralyn M; Palomaki Glenn E; Neveux Louis M; Malone Fergal D; Ball Robert H; Nyberg David A; Comstock Christine H; Bukowski Radek; Saade George R; Berkowitz Richard L; Dar Pe'er; Dugoff Lorraine; Craigo Sabrina D; Timor-Tritsch Ilan E; Carr Stephen R; Wolfe Honor M; D'Alton Mary E;
Comparison of serum markers in first-trimester down syndrome screening.
Obstetrics and gynecology 2006;108(5):1192-9.
2006: Kavsak Peter A; MacRae Andrew R; Palomaki Glenn E; Newman Alice M; Ko Dennis T; Lustig Viliam; Tu Jack V; Jaffe Allan S
Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients.
Clinical chemistry 2006;52(11):2028-35.
2006: Craig Wendy Y; Haddow James E; Palomaki Glenn E; Kelley Richard I; Kratz Lisa E; Shackleton Cedric H L; Marcos Josep; Stephen Tint G; MacRae Andrew R; Nowaczyk Malgorzata J; Kloza Edward M; Irons Mira B; Roberson Marie
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome.
Prenatal diagnosis 2006;26(9):842-9.
2006: Palomaki Glenn E; Wright David E; Summers Anne M; Neveux Louis M; Meier Christian; O'donnell Andrea; Huang Tianhua; Knight George J; Haddow James E
Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Prenatal diagnosis 2006;26(8):730-9.
2006: Kavsak Peter A; MacRae Andrew R; Lustig Viliam; Bhargava Rakesh; Vandersluis Rudy; Palomaki Glenn E; Yerna Marie-Jeanne; Jaffe Allan S
The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.
American heart journal 2006;152(1):118-25.
2006: Macrae Andrew R; Kavsak Peter A; Lustig Viliam; Bhargava Rakesh; Vandersluis Rudy; Palomaki Glenn E; Yerna Marie-Jeanne; Jaffe Allan S
Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.
Clinical chemistry 2006;52(5):812-8.
2006: Palomaki Glenn E; McClain Monica R; Steinort Klaus; Sifri Randa; LoPresti Leigh; Haddow James E
Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(3):161-8.
2006: Haddow James E; McClain Monica R; Palomaki Glenn E; Kloza Edward M; Williams Josephine
Screening for thyroid disorders during pregnancy: results of a survey in Maine.
American journal of obstetrics and gynecology 2006;194(2):471-4.
2006: Palomaki Glenn E; Steinort Klaus; Knight George J; Haddow James E
Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Obstetrics and gynecology 2006;107(2 Pt 1):367-75.
2006: Haddow James E; Palomaki Glenn E; McClain Monica R
Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges.
Obstetrics and gynecology 2006;107(1):205-6; author reply 206.
2006: Bdolah Yuval; Palomaki Glenn E; Yaron Yuval; Bdolah-Abram Tali; Goldman Marlene; Levine Richard J; Sachs Benjamin P; Haddow James E; Karumanchi S Ananth
Circulating angiogenic proteins in trisomy 13.
American journal of obstetrics and gynecology 2006;194(1):239-45.
2006: Lambert-Messerlian Geralyn M; Eklund Elizabeth E; Malone Fergal D; Palomaki Glenn E; Canick Jacob A; D'Alton Mary E
Stability of first- and second-trimester serum markers after storage and shipment.
Prenatal diagnosis 2006;26(1):17-21.
2006: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Ledue Thomas B; Marcovina Santica; Navolotskaia Olga
Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 2006;20(5):218-26.
2006: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Ledue Thomas B; Craig Wendy Y; Marcovina Santica; Navolotskaia Olga
Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 2006;20(5):209-17.
2005: Knight George J; Palomaki Glenn E; Neveux Louis M; Smith Dwight E; Kloza Edward M; Pulkkinen Andrea J; Williams Josephine; Haddow James E
Integrated serum screening for Down syndrome in primary obstetric practice.
Prenatal diagnosis 2005;25(12):1162-7.
2005: Palomaki Glenn E; Kloza Edward M; Haddow James E; Williams Josephine; Knight George J
Patient and health professional acceptance of integrated serum screening for Down syndrome.
Seminars in perinatology 2005;29(4):247-51.
2005: Palomaki Glenn E; Knight George J; Neveux Louis M; Pandian Raj; Haddow James E
Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening.
Clinical chemistry 2005;51(8):1499-504.
2005: Spector Elaine B; Grody Wayne W; Matteson Carla J; Palomaki Glenn E; Bellissimo Daniel B; Wolff Daynna J; Bradley Linda A; Prior Thomas W; Feldman Gerald; Popovich Bradley W; Watson Michael S; Richards C Sue
Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(6):444-53.
2005: Bradley Linda A; Palomaki Glenn E; McDowell Geraldine A;
Technical standards and guidelines: prenatal screening for open neural tube defects.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(5):355-69.
2005: Palomaki Glenn E; Bradley Linda A; McDowell Geraldine A;
Technical standards and guidelines: prenatal screening for Down syndrome.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(5):344-54.
2005: Schreiber William E; Endres David B; McDowell Geraldine A; Palomaki Glenn E; Elin Ronald J; Klee George G; Wang Edward
Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen.
Archives of pathology & laboratory medicine 2005;129(3):331-7.
2005: Knight George J; Palomaki Glenn E; Klee George G; Schreiber William E; Cole Lawrence A
A comparison of human chorionic gonadotropin- related components in fresh frozen serum with the proficiency testing material used by the College of American Pathologists.
Archives of pathology & laboratory medicine 2005;129(3):328-30.
2005: Isman Ferruh; Palomaki Glenn E; Natowicz Marvin R
Lysosomal enzymes in human peripheral blood mononuclear cells and granulocytes.
Clinical chemistry 2005;51(3):646-9.
2005: McClain Monica R; Nathanson Katherine L; Palomaki Glenn E; Haddow James E
An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):34-9.
2005: McClain Monica R; Palomaki Glenn E; Nathanson Katherine L; Haddow James E
Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):28-33.
2004: Palomaki Glenn E; Neveux Louis M; Knight George J; Haddow James E; Pandian Raj
Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
Clinical chemistry 2004;50(10):1804-8.
2004: Palomaki Glenn E; FitzSimmons Stacey C; Haddow James E
Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(5):405-14.
2004: Watson Michael S; Cutting Garry R; Desnick Robert J; Driscoll Deborah A; Klinger Katherine; Mennuti Michael; Palomaki Glenn E; Popovich Bradley W; Pratt Victoria M; Rohlfs Elizabeth M; Strom Charles M; Richards C Sue; Witt David R; Grody Wayne W
Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(5):387-91.
2004: Pandian Raj; Cole Laurence A; Palomaki Glenn E
Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening.
Clinical chemistry 2004;50(8):1433-5.
2004: McClain Monica R; Palomaki Glenn E; Haddow James E
Is first trimester measurement of sex hormone binding globulin a possible screening test for gestational diabetes mellitus.
American journal of obstetrics and gynecology 2004;190(6):1808-9;author reply 1809.
2004: Palomaki Glenn E
Prenatal screening for cystic fibrosis: an early report card.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(3):115-6.
2004: Palomaki Glenn E; Knight George J; Roberson Marie M; Cunningham George C; Lee Jo Ellen; Strom Charles M; Pandian Raj
Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for down syndrome: preliminary results of an observational study on fresh samples.
Clinical chemistry 2004;50(1):182-9.
2004: Haddow J E; Knight G J; Palomaki G E; McClain M R; Pulkkinen A J
The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.
Journal of medical screening 2004;11(4):170-4.
2004: Ritchie Robert F; Palomaki Glenn
Selecting clinically relevant populations for reference intervals.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(7):702-9.
2004: Lambert-Messerlian Geralyn; Halliday Jacquelyn; Williams Josephine; Cain Rachel; Msall Michael E; Palomaki Glenn E; Canick Jacob A
Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island.
Journal of medical screening 2004;11(2):106-7.
2004: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Navolotskaia Olga
Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 2004;18(2):148-52.
2004: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Navolotskaia Olga; Ledue Thomas B; Craig Wendy Y
Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 2004;18(2):139-47.
2004: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Navolotskaia Olga
Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 2004;18(1):9-13.
2004: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Navolotskaia Olga; Ledue Thomas B; Craig Wendy Y
Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 2004;18(1):1-8.
2003: Palomaki Glenn E; Haddow James E; Bradley Linda A; Richards C Sue; Stenzel Timothy T; Grody Wayne W
Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(6):440-3.
2003: Knight George J; Palomaki Glenn E
Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome.
Clinics in laboratory medicine 2003;23(2):531-51, xi.
2003: Palomaki Glenn E; Neveux Louis M; Knight George J; Haddow James E
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Prenatal diagnosis 2003;23(3):243-7.
2003: Farina Antonio; LeShane Erik S; Lambert-Messerlian Geralyn M; Canick Jacob A; Lee Thomas; Neveux Louis M; Palomaki Glenn E; Bianchi Diana W
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy.
Clinical chemistry 2003;49(2):239-42.
2003: Palomaki Glenn E; Bradley Linda A; Richards C Sue; Haddow James E
Analytic validity of cystic fibrosis testing: a preliminary estimate.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(1):15-20.
2002: Haddow James E; Palomaki Glenn E; Williams Josephine
Thyroid-stimulating-hormone concentrations and risk of hypothyroidism.
Lancet 2002;360(9350):2081-2; author reply 2082.
2002: Richards Carolyn Sue; Bradley Linda A; Amos Jean; Allitto Bernice; Grody Wayne W; Maddalena Anne; McGinnis Matthew J; Prior Thomas W; Popovich Bradley W; Watson Michael S; Palomaki Glenn E
Standards and guidelines for CFTR mutation testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2002;4(5):379-91.
2002: Burke Wylie; Atkins David; Gwinn Marta; Guttmacher Alan; Haddow James; Lau Joseph; Palomaki Glenn; Press Nancy; Richards C Sue; Wideroff Louise; Wiesner Georgia L
Genetic test evaluation: information needs of clinicians, policy makers, and the public.
American journal of epidemiology 2002;156(4):311-8.
2002: Palomaki Glenn E; Haddow James E; Bradley Linda A; FitzSimmons Stacey C
Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians.
Genetics in medicine : official journal of the American College of Medical Genetics 2002;4(2):90-4.
2002: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Navolotskaia Olga; Ledue Thomas B; Craig Wendy Y
Reference distributions for serum iron and transferrin saturation: a comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 2002;16(5):246-52.
2002: Ritchie Robert F; Palomaki Glenn E; Neveux Louis M; Navolotskaia Olga; Ledue Thomas B; Craig Wendy Y
Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 2002;16(5):237-45.
2002: Palomaki G E; Bradley L A; Knight G J; Craig W Y; Haddow J E
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome.
Journal of medical screening 2002;9(1):43-4.
2001: Palomaki G E; Neveux L M
Using multiples of the median to normalize serum protein measurements.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(11):1137-45.
2001: Allan W C; Timothy K; Vincent G M; Palomaki G E; Neveux L M; Haddow J E
Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting.
Journal of medical screening 2001;8(4):178-82.
2001: Allan W C; Timothy K; Vincent G M; Palomaki G E; Neveux L M; Haddow J E
Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population.
Journal of medical screening 2001;8(4):173-7.
2001: Knight G J; Palomaki G E; Neveux L M; Haddow J E; Lambert-Messerlian G M
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
Journal of medical screening 2001;8(1):2-7.
2000: Mitchell M L; Hermos R J; Larson C A; Palomaki G E; Haddow J E
Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
Diabetes care 2000;23(11):1705-6.
2000: Lambert-Messerlian G M; Palomaki G E; Canick J A
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects.
Prenatal diagnosis 2000;20(8):680-2.
2000: Ritchie R F; Palomaki G E; Neveux L M; Navolotskaia O; Ledue T B; Craig W Y
Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 2000;14(6):284-92.
2000: Ritchie R F; Palomaki G E; Neveux L M; Navolotskaia O
Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 2000;14(6):265-70.
2000: Allan W C; Haddow J E; Palomaki G E; Williams J R; Mitchell M L; Hermos R J; Faix J D; Klein R Z
Maternal thyroid deficiency and pregnancy complications: implications for population screening.
Journal of medical screening 2000;7(3):127-30.
1999: Saller D N; Canick J A; Blitzer M G; Palomaki G E; Schwartz S; Blakemore K J; Haddow J E
Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
Prenatal diagnosis 1999;19(9):813-6.
1999: Haddow J E; Palomaki G E; Allan W C; Williams J R; Knight G J; Gagnon J; O'Heir C E; Mitchell M L; Hermos R J; Waisbren S E; Faix J D; Klein R Z
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.
The New England journal of medicine 1999;341(8):549-55.
1999: Bradley L A; Palomaki G E; Knight G J; Haddow J E; Opitz J M; Irons M; Kelley R I; Tint G S
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses.
American journal of medical genetics 1999;82(4):355-8.
1999: Ritchie R F; Palomaki G E; Neveux L M; Navolotskaia O
Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 1999;13(6):280-6.
1999: Ritchie R F; Palomaki G E; Neveux L M; Navolotskaia O; Ledue T B; Craig W Y
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 1999;13(6):273-9.
1999: Haddow J E; Bradley L A; Palomaki G E; Doherty R A
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.
Journal of medical screening 1999;6(2):60-6.
1998: Craig W Y; Neveux L M; Palomaki G E; Cleveland M M; Haddow J E
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.
Clinical chemistry 1998;44(11):2301-6.
1998: Haddow J E; Palomaki G E; Knight G J; Williams J; Miller W A; Johnson A
Screening of maternal serum for fetal Down's syndrome in the first trimester.
The New England journal of medicine 1998;338(14):955-61.
1998: Knight G J; Palomaki G E; Neveux L M; Fodor K K; Haddow J E
hCG and the free beta-subunit as screening tests for Down syndrome.
Prenatal diagnosis 1998;18(3):235-45.
1998: Ritchie R F; Palomaki G E; Neveux L M; Navolotskaia O
Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature.
Journal of clinical laboratory analysis 1998;12(6):371-7.
1998: Ritchie R F; Palomaki G E; Neveux L M; Navolotskaia O; Ledue T B; Craig W Y
Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort.
Journal of clinical laboratory analysis 1998;12(6):363-70.
1998: Haddow J E; Palomaki G E; Knight G J; Foster D L; Neveux L M
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Journal of medical screening 1998;5(3):115-9.
1998: Bradley L A; Johnson D D; Palomaki G E; Haddow J E; Robertson N H; Ferrie R M
Hereditary haemochromatosis mutation frequencies in the general population.
Journal of medical screening 1998;5(1):34-6.
1997: Kellner L H; Canick J A; Palomaki G E; Neveux L M; Saller D N; Walker R P; Osathanondh R; Bombard A T
Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome.
Prenatal diagnosis 1997;17(12):1135-41.
1997: Cole L A; Acuna E; Isozaki T; Palomaki G E; Bahado-Singh R O; Mahoney M O
Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Prenatal diagnosis 1997;17(12):1125-33.
1997: Cole L A; Jacobs M; Isozaki T; Palomaki G E; Bahado-Singh R O; Mahoney M J
Screening for Down syndrome using urine hCG free beta-subunit in the second trimester of pregnancy.
Prenatal diagnosis 1997;17(12):1107-11.
1997: Cole L A; Kellner L H; Isozaki T; Palomaki G E; Iles R K; Walker R P; Ozaki M; Canick J A
Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies.
Prenatal diagnosis 1997;17(7):607-14.
1997: Isozaki T; Palomaki G E; Bahado-Singh R O; Cole L A
Screening for Down syndrome pregnancy using beta-core fragment: prospective study.
Prenatal diagnosis 1997;17(5):407-13.
1997: Palomaki G E; Knight G J; McCarthy J E; Haddow J E; donhowe J M
Maternal serum screening for Down syndrome in the United States: a 1995 survey.
American journal of obstetrics and gynecology 1997;176(5):1046-51.
1997: Bradley L A; Canick J A; Palomaki G E; Haddow J E
Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency.
American journal of obstetrics and gynecology 1997;176(3):531-5.
1997: Star J; Canick J A; Palomaki G E; Carpenter M W; Saller D N; Sung C J; Tumber M B; Coustan D R
The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes.
Prenatal diagnosis 1997;17(2):149-54.
1996: Cole L; Isozaki T; Palomaki G; Canick J; Iles R; Kellner L; Saller D; Cuckle H
Detection of beta-core fragment in second trimester Down's syndrome pregnancies.
Early human development 1996;47 Suppl():S47-8.
1996: Neveux L M; Palomaki G E; Larrivee D A; Knight G J; Haddow J E
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Prenatal diagnosis 1996;16(12):1115-9.
1996: Haddow J E; Palomaki G E; Knight G J; Williams J; Chilmonczyk B A
Intervening to reduce environmental tobacco smoke exposure in infants.
Pediatrics 1996;98(3 Pt 1):513.
1996: Doherty R A; Palomaki G E; Kloza E M; Erickson J L; Haddow J E
Couple-based prenatal screening for cystic fibrosis in primary care settings.
Prenatal diagnosis 1996;16(5):397-404.
1996: Neveux L M; Palomaki G E; Knight G J; Haddow J E
Multiple marker screening for Down syndrome in twin pregnancies.
Prenatal diagnosis 1996;16(1):29-34.
1996: Lambert-Messerlian G M; Canick J A; Palomaki G E
Maternal serum total activin A in pregnancies affected with fetal Down's syndrome.
Journal of medical screening 1996;3(4):217.
1996: Bradley L A; Haddow J E; Palomaki G E
Population screening for haemochromatosis: a unifying analysis of published intervention trials.
Journal of medical screening 1996;3(4):178-84.
1996: Bradley L A; Haddow J E; Palomaki G E
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
Journal of medical screening 1996;3(4):171-7.
1996: Palomaki G E; Neveux L M; Haddow J E
Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?
Journal of medical screening 1996;3(1):12-7.
1996: Lambert-Messerlian G M; Canick J A; Palomaki G E; Schneyer A L
Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
Journal of medical screening 1996;3(2):58-62.
1995: Wald N J; Kennard A; Watt H; Haddow J E; Palomaki G E; Knight G; Canick J A
Decision analysis and screening for Down's syndrome. Testing should be in all women.
BMJ (Clinical research ed.) 1995;311(7016):1372-3.
1995: Craig W Y; Poulin S E; Neveux L M; Palomaki G E; Dostal-Johnson D A; Ledue T B; Ritchie R F
Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytes.
Journal of autoimmunity 1995;8(5):713-26.
1995: Canick J A; Kellner L H; Saller D N; Palomaki G E; Walker R P; Osathanondh R
Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy.
Prenatal diagnosis 1995;15(8):739-44.
1995: Palomaki G E; Haddow J E; Knight G J; Wald N J; Kennard A; Canick J A; Saller D N; Blitzer M G; Dickerman L H; Fisher R
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Prenatal diagnosis 1995;15(8):713-23.
1995: Craig W Y; Poulin S E; Palomaki G E; Neveux L M; Ritchie R F; Ledue T B
Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(6):733-9.
1995: Palomaki G E; Williams J; Haddow J E; Natowicz M R
Tay-Sachs disease in persons of French-Canadian heritage in northern New England.
American journal of medical genetics 1995;56(4):409-12.
1995: Haddow J E; Palomaki G E; Knight G J
Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening.
Journal of medical screening 1995;2(1):28-30.
1994: Donnenfeld A E; Carlson D E; Palomaki G E; Librizzi R J; Weiner S; Platt L D
Prospective multicenter study of second-trimester nuchal skinfold thickness in unaffected and Down syndrome pregnancies.
Obstetrics and gynecology 1994;84(5):844-7.
1994: Johnson A M; Ledue T B; Palomaki G E; Craig W Y
Effect of storage at -70 degrees C on immunoturbidimetric assays for apolipoproteins A-I and B.
Clinica chimica acta; international journal of clinical chemistry 1994;231(1):89-94.
1994: Rose N C; Canick J A; Knight G J; Pulkkinen A; Tumber M B; Mennuti M T; Palomaki G E
Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
Prenatal diagnosis 1994;14(10):947-51.
1994: Palomaki G E; Bradley L A; Haddow J E
A new approach to analysing fluorescence in situ hybridisation data for rapid detection of aneuploidy in amniocytes.
Journal of medical screening 1994;1(2):96-7.
1994: Haddow J E; Knight G J; Palomaki G E; Neveux L M; Chilmonczyk B A
Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations.
Clinical chemistry 1994;40(4):562-4.
1994: Rose N C; Palomaki G E; Haddow J E; Goodman D B; Mennuti M T
Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older.
American journal of obstetrics and gynecology 1994;170(4):1073-8; discussion 1078-80.
1994: Haddow J E; Palomaki G E; Knight G J; Cunningham G C; Lustig L S; Boyd P A
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
The New England journal of medicine 1994;330(16):1114-8.
1994: Palomaki G E
Population based prenatal screening for the fragile X syndrome.
Journal of medical screening 1994;1(1):65-72.
1994: Doherty R A; Palomaki G E; Kloza E M; Erickson J L; Dostal D A; Haddow J E
Prenatal screening for cystic fibrosis.
Lancet 1994;343(8890):172.
1994: Palomaki G E; Knight G J; Haddow J E
Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
Prenatal diagnosis 1994;14(1):65-8.
1993: Ledue T B; Neveux L M; Palomaki G E; Ritchie R F; Craig W Y
The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response.
Clinica chimica acta; international journal of clinical chemistry 1993;223(1-2):73-82.
1993: Palomaki G E; Knight G J; McCarthy J; Haddow J E; Eckfeldt J H
Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey.
American journal of obstetrics and gynecology 1993;169(6):1558-62.
1993: Chilmonczyk B A; Salmun L M; Megathlin K N; Neveux L M; Palomaki G E; Knight G J; Pulkkinen A J; Haddow J E
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children.
The New England journal of medicine 1993;328(23):1665-9.
1993: Palomaki G E; Knight G J; Haddow J E; Canick J A; Wald N J; Kennard A
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):675-8.
1993: Haddow J E; Palomaki G E; Holman M S
Young maternal age and smoking during pregnancy as risk factors for gastroschisis.
Teratology 1993;47(3):225-8.
1993: Donnenfeld A E; Pulkkinen A; Palomaki G E; Knight G J; Haddow J E
Simultaneous fetal and maternal cotinine levels in pregnant women smokers.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):781-2.
1992: Palomaki G E; Knight G J; Haddow J E; Canick J A; Saller D N; Panizza D S
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Prenatal diagnosis 1992;12(11):925-30.
1992: Haddow J E; Palomaki G E; Knight G J; Williams J; Pulkkinen A; Canick J A; Saller D N; Bowers G B
Prenatal screening for Down's syndrome with use of maternal serum markers.
The New England journal of medicine 1992;327(9):588-93.
1992: Chilmonczyk B A; Palomaki G E; Knight G J; Williams J; Haddow J E
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy.
American journal of diseases of children (1960) 1992;146(3):357-60.
1992: Haddow J E; Holman M S; Palomaki G E
Can gestational dates routinely derived from very early ultrasound be used to interpret maternal serum alpha-fetoprotein measurements?
Prenatal diagnosis 1992;12(1):65-8.
1991: Rose N C; Haddow J E; Palomaki G E; Knight G J
Self-rated physical activity level during the second trimester and pregnancy outcome.
Obstetrics and gynecology 1991;78(6):1078-80.
1991: Haddow J E; Rote N S; Dostal-Johnson D; Palomaki G E; Pulkkinen A J; Knight G J
Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester.
American journal of obstetrics and gynecology 1991;165(5 Pt 1):1308-12.
1991: Haddow J E; Knight G J; Kloza E M; Palomaki G E; Wald N J
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery.
British journal of obstetrics and gynaecology 1991;98(9):859-65.
1990: Canick J A; Knight G J; Palomaki G E; Haddow J E
Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida.
Prenatal diagnosis 1990;10(11):733-7.
1990: Chilmonczyk B A; Knight G J; Palomaki G E; Pulkkinen A J; Williams J; Haddow J E
Environmental tobacco smoke exposure during infancy.
American journal of public health 1990;80(10):1205-8.
1990: Canick J A; Palomaki G E; Osathanondh R
Prenatal screening for trisomy 18 in the second trimester.
Prenatal diagnosis 1990;10(8):546-8.
1990: Johnson A M; Palomaki G E; Haddow J E
The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study.
American journal of obstetrics and gynecology 1990;163(1 Pt 1):9-11.
1990: Craig W Y; Palomaki G E; Johnson A M; Haddow J E
Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis.
Pediatrics 1990;85(2):155-8.
1990: Johnson A M; Palomaki G E; Haddow J E
Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study.
American journal of obstetrics and gynecology 1990;162(2):328-31.
1990: Palomaki G E; Knight G J; Holman M S; Haddow J E
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey.
American journal of obstetrics and gynecology 1990;162(2):317-21.
1989: Goldfine C; Haddow J E; Knight G J; Palomaki G E
Amniotic fluid alpha-fetoprotein and acetylcholinesterase measurements in pregnancies associated with gastroschisis.
Prenatal diagnosis 1989;9(10):697-700.
1989: Knight G J; Palomaki G E; Lea D H; Haddow J E
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay.
Clinical chemistry 1989;35(6):1036-9.
1989: Goldfine C; Knight G J; Haddow J E; Palomaki G E
Amniotic fluid acetylcholinesterase measurements: comparing immunochemical and polyacrylamide gel techniques.
Prenatal diagnosis 1989;9(3):167-72.
1989: Craig W Y; Palomaki G E; Haddow J E
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.
BMJ (Clinical research ed.) 1989;298(6676):784-8.
1988: Haddow J E; Knight G J; Palomaki G E; McCarthy J E
Second-trimester serum cotinine levels in nonsmokers in relation to birth weight.
American journal of obstetrics and gynecology 1988;159(2):481-4.
1988: Knight G J; Palomaki G E; Haddow J E
Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome.
Clinical obstetrics and gynecology 1988;31(2):306-27.
1988: Palomaki G E; Hill L E; Knight G J; Haddow J E; Carpenter M
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Obstetrics and gynecology 1988;71(6 Pt 1):906-9.
1988: Canick J A; Knight G J; Palomaki G E; Haddow J E; Cuckle H S; Wald N J
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
British journal of obstetrics and gynaecology 1988;95(4):330-3.
1987: Haddow J E; Knight G J; Palomaki G E; Kloza E M; Wald N J
Cigarette consumption and serum cotinine in relation to birthweight.
British journal of obstetrics and gynaecology 1987;94(7):678-81.
1987: Haddow J E; Hill L E; Palomaki G E; Knight G J
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
Prenatal diagnosis 1987;7(6):401-6.
1986: Haddow J E; Knight G J; Kloza E M; Palomaki G E
Alpha-fetoprotein, vaginal bleeding and pregnancy risk.
British journal of obstetrics and gynaecology 1986;93(6):589-93.
1985: Palomaki G E; Knight G J; Kloza E M; Haddow J E
Maternal weight adjustment and low serum alpha-fetoprotein values.
Lancet 1985;1(8426):468.
1984: Haddow J E; Palomaki G; Kloza E M; Knight G J
Does smoking influence serum alpha-fetoprotein levels in mid-trimester pregnancies?
British journal of obstetrics and gynaecology 1984;91(12):1188-91.

Sign-in to see more